Data / Crowdfunding / California / Rejuve Biotech Inc.
Rejuve Biotech Inc.: crowdfunding raise on NetCapital Funding Portal Inc., $10,004 to $4,999,999 (2024)
Rejuve Biotech Inc., a corporation in Orange, CA, filed a Form C with the SEC on September 13, 2024 to raise $10,004 to $4,999,999 in common stock through NetCapital Funding Portal Inc.. The offering closed on December 6, 2024. In its most recent fiscal year it reported $0 in revenue and a net loss of $57,800, with 6 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.rejuve.bio
- Funding portal
- NetCapital Funding Portal Inc.
- Address
- 215 S Orange St 215 South Orange Street, Orange, CA 92866
- Legal form
- Corporation
- Jurisdiction
- CA
- Incorporated
- December 1, 2022
- SEC CIK
- 0001994911
Offering terms
From the amendment filed September 13, 2024.
- Security
- Common Stock
- Price
- $8.33
- Target
- $10,004
- Maximum
- $4,999,999
- Deadline
- December 6, 2024
- Portal compensation
- Up to 4.9% of amount raised for a successful offering and a listing fee of up to $10,000
Financials
From the Form C-AR filed May 7, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-57,800 | $-13,513 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $136,091 | $257,811 | sec.gov |
| Cash | $136,091 | $257,811 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $0 | $0 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| May 7, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| April 30, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| February 21, 2025 | Progress update | $10,004 | $4,999,999 | December 6, 2024 | End of offering. Issuer closed its offering with estimated gross proceeds of $288,551. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption. | sec.gov |
| September 13, 2024 | Amendment | $10,004 | $4,999,999 | December 6, 2024 | issuer extended the offering deadline. | sec.gov |
| June 26, 2024 | Amendment | $10,004 | $4,999,999 | September 13, 2024 | issuer extended the offering deadline. | sec.gov |
| April 26, 2024 | Amendment | $10,004 | $4,999,999 | June 28, 2024 | issuer extended the offering deadline and updated the offering statement to include 2023 financial information. | sec.gov |
| March 12, 2024 | Amendment | $10,004 | $4,999,999 | April 26, 2024 | updated cover image | sec.gov |
| February 27, 2024 | Amendment | $10,004 | $4,999,999 | April 26, 2024 | updated use of proceeds and team section. | sec.gov |
| February 20, 2024 | Offering | $10,004 | $4,999,999 | April 26, 2024 | sec.gov |
Updated May 7, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.